Key statistics
As of last trade, Equasens SA (PHF:STU) traded at 38.20, 22.24% above the 52 week low of 31.25 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 38.50 |
|---|---|
| High | 38.75 |
| Low | 38.10 |
| Bid | 38.20 |
| Offer | 38.35 |
| Previous close | 38.65 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 15.17m |
| Free float | 5.03m |
| P/E (TTM) | 15.99 |
| Market cap | 580.41m EUR |
| EPS (TTM) | 2.39 EUR |
| Annual div (ADY) | 1.25 EUR |
|---|---|
| Annual div yield (ADY) | 3.23% |
| Div ex-date | Jul 02 2025 |
| Div pay-date | Jul 04 2025 |
Data delayed at least 15 minutes, as of Feb 09 2026.
More ▼
Announcements
- Solides performances commerciales en 2025 : revenu annuel récurrent (ARR) de 108,0 M€ (+8,8% en publié au 31/12/25) et chiffre d’affaires annuel de 236,5 M€ (+9,1% en publié)
- Strong commercial performance in 2025: Annual Recurring Revenue (ARR) of €108.0m (+8.8% as reported on 31 December 2025) and full-year revenue of €236.5m (+9.1% as reported)
- BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT
- EQUASENS ACCELERATES ITS DIGITAL TRAINING STRATEGY FOR HEALTHCARE PROFESSIONALS WITH THE ACQUISITION OF EREVO, A LEADING PURE-PLAY E-LEARNING PROVIDER
- EQUASENS ACCELERE DANS LA FORMATION DIGITALE DEDIEE AUX PROFESSIONNELS DE SANTE AVEC L’ACQUISITION D’EREVO, LEADER « PURE PLAYER » DU E-LEARNING
- EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR
- EQUASENS ANNONCE SON AGENDA FINANCIER 2026
- EQUASENS : Chiffre d'affaires au 30 septembre 2025
- Equasens: Q3 2025 revenue
- EQUASENS : Mise à disposition du rapport financier semestriel 2025
More ▼
